Kairos Pharma, Ltd.
KAPA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17 | $27 | $27 | $33 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $1 | $0 |
| Enterprise Value | $16 | $28 | $27 | $34 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$0 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.23 | -0.17 | -0.1 | -0.17 |
| % Growth | -35.3% | -70% | 41.2% | – |
| Operating Cash Flow | -$4 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | $0 | -$0 | -$0 |